{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Insight Molecular Diagnostics Inc."},"Symbol":{"label":"Symbol","value":"IMDX"},"Address":{"label":"Address","value":"2 INTERNATIONAL PLAZA DR.,SUITE 510, NASHVILLE, 37217, United States"},"Phone":{"label":"Phone","value":"+1 949 409-7600"},"Industry":{"label":"Industry","value":"Biotechnology: In Vitro & In Vivo Diagnostic Substances"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Insight Molecular Diagnostics Inc., or iMDx (formerly Oncocyte Corporation), is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. Investors may visit https://investors.imdxinc.com/ for more information."},"CompanyUrl":{"label":"Company Url","value":"https://www.oncocyte.com"}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}